Rare diseases
Investigational molecules
Locations
ul. Armii Krajowej 43a, 94-046 Lodz, Poland
NZOZ ALL-MED Centrum Medyczne in Lodz, Poland specialises in clinical trials of conditions such as Atrial fibrillation, Chronic cutaneous lupus erythematosus, Cutaneous lupus erythematosus, Subacute cutaneous lupus erythematosus, and other specialisations. This site conducts important research.
The research at NZOZ ALL-MED Centrum Medyczne includes a study on atrial fibrillation evaluating the novel therapy abelacimab for reducing stroke risk in patients unsuitable for oral anticoagulants.
The site in Łódź, Poland, is advancing cardiovascular care by testing innovative treatments for high‑risk heart rhythm disorders.
At NZOZ ALL-MED Centrum Medyczne, investigators are conducting a trial on Active Discoid and/or Subacute Cutaneous Lupus Erythematosus to determine the efficacy of the selective inhibitor deucravacitinib on skin disease activity.
This research supports the development of new therapeutic options for immune‑mediated skin conditions.
Clinical trials currently enrolling participants at this site.
Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
PolandStudy on the Safety and Effectiveness of Deucravacitinib for Patients with Active Discoid and/or Subacute Cutaneous Lupus Erythematosus
PolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
